ADC Therapeutics SA Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for ADC Therapeutics SA (ADCT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-157.85-240.05-157.13-230.03-246.29
Depreciation & Amortization3.283.272.392.631.97
Deferred Income Tax0.0037.10-1.62-26.050.33
Stock Based Compensation6.5713.5049.3260.4837.59
Change in Working Capital3.8344.27-48.73-15.7112.36
Change in Accounts Receivable4.7747.79-42.75-30.220.00
Change in Inventory-3.73-5.71-9.65-3.020.00
Change in Accounts Payable2.463.170.316.801.92
Change in Other Working Capital17.76-0.98-25.41-17.0610.44
Other Operating Activities17.7651.79-25.41-17.0683.00
Net Cash from Operating Activities-123.84-118.69-138.31-233.38-168.83
Investing Activities
Capital Expenditures-0.87-3.22-0.69-6.382.81
Sales/Maturities of Investments0.000.000.00-2.95-2.01
Other Investing Activities0.000.000.00-0.30-0.02
Net Cash from Investing Activities-0.87-3.22-0.69-6.67-2.83
Financing Activities
Debt Repayment0.000.00-1.01-0.98-1.14
Common Stock Issued60.510.776.130.78433.16
Common Stock Repurchased-1.160.00-0.220.000.00
Other Financing Activities-1.1673.10-122.62218.000.00
Net Cash from Financing Activities97.0573.88-0.90267.39495.07
Summary
Effect of Forex Changes on Cash-0.080.18-0.210.010.00
Net Change in Cash-27.65-47.84-139.9027.34323.41
Cash at Beginning of Period278.60326.44466.54439.20115.55
Cash at End of Period250.87-51.04326.44466.54438.96
Free Cash Flow-124.70-121.90-139.00-239.75-171.64
Supplemental Disclosures
Interest Paid15.7015.3910.185.281.56
Income Taxes Paid0.000.000.000.670.03